The Food and Drug Administration issued a warning recently that potential heart risks when combining two HIV drugs. The agency said preliminary data suggest Roche’s Invirase and Abbott Laboratories’ Norvir can affect the electrical activity of the heart when used together. Changes to the heart’s electrical activity can delay the signals that trigger heart beats. In some cases the problem can cause irregular heart rhythms, leading to lightheadedness, fainting, and even death.
You can read the full Reuters article here.
HIV Prevention and Care Project 